Literature DB >> 17626101

Differential functional avidity of dengue virus-specific T-cell clones for variant peptides representing heterologous and previously encountered serotypes.

Allison Imrie1, Janet Meeks, Alexandra Gurary, Munkhzul Sukhbataar, Paul Kitsutani, Paul Effler, Zhengshan Zhao.   

Abstract

Proinflammatory cytokines secreted by memory CD8+ and CD4+ T cells are thought to play a direct role in the pathogenesis of dengue virus infection by increasing vascular permeability and thereby inducing the pathophysiologic events associated with dengue hemorrhagic fever and dengue shock syndrome. Severe disease is frequently observed in the setting of secondary infection with heterologous dengue virus serotypes, suggesting a role for cross-reactive memory T cells in the immunopathogenesis of severe disease. We used a large panel of well-characterized dengue virus-specific CD8+ T-cell clones isolated from Pacific Islanders previously infected with dengue virus 1 to examine effector memory function, focusing on a novel dominant HLA-B*5502-restricted NS5(329-337) epitope, and assessed T-cell responses to stimulation with variant peptides representing heterologous serotypes. Variant peptides were differentially recognized by dengue virus 1-specific effector CD8+ cytotoxic T lymphocytes (CTL) in a heterogeneous and clone-specific manner, in which cytolytic function and cytokine secretion could be enhanced, diminished, or abrogated compared with cognate peptide stimulation. Dengue virus-specific CTL stimulated with cognate and variant peptides demonstrated a cytokine response hierarchy of gamma IFN (IFN-gamma) > tumor necrosis factor alpha (TNF-alpha) > interleukin-2 (IL-2), and a subset of clones also produced IL-4 and IL-6. Individual clones demonstrated greater avidity for variant peptides representing heterologous serotypes, including serotypes previously encountered by the subject, and IFN-gamma and TNF-alpha secretion was enhanced by stimulation with these heterologous peptides. Altered antiviral T-cell responses in response to stimulation with heterologous dengue virus serotypes have implications for control of virus replication and for disease pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17626101      PMCID: PMC2045385          DOI: 10.1128/JVI.00330-07

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  32 in total

1.  Molecular epidemiology of dengue in the Pacific: introduction of two distinct strains of dengue virus type-1 [corrected] into Hawaii.

Authors:  A Imrie; Z Zhao; S N Bennett; P Kitsutani; M Laille; P Effler
Journal:  Ann Trop Med Parasitol       Date:  2006-06

2.  Sequential infection as risk factor for dengue hemorrhagic fever/dengue shock syndrome (DHF/DSS) during the 1981 dengue hemorrhagic Cuban epidemic.

Authors:  M G Guzmán; G Kouri; J Bravo; M Soler; E Martínez
Journal:  Mem Inst Oswaldo Cruz       Date:  1991 Jul-Sep       Impact factor: 2.743

3.  Original antigenic sin impairs cytotoxic T lymphocyte responses to viruses bearing variant epitopes.

Authors:  P Klenerman; R M Zinkernagel
Journal:  Nature       Date:  1998-07-30       Impact factor: 49.962

4.  Cross-reactivities in memory cytotoxic T lymphocyte recognition of heterologous viruses.

Authors:  L K Selin; S R Nahill; R M Welsh
Journal:  J Exp Med       Date:  1994-06-01       Impact factor: 14.307

Review 5.  Immunopathologic mechanisms of dengue hemorrhagic fever and dengue shock syndrome.

Authors:  I Kurane; A L Rothman; P G Livingston; S Green; S J Gagnon; J Janus; B L Innis; S Nimmannitya; A Nisalak; F A Ennis
Journal:  Arch Virol Suppl       Date:  1994

6.  Induction of T-cell anergy by altered T-cell-receptor ligand on live antigen-presenting cells.

Authors:  J Sloan-Lancaster; B D Evavold; P M Allen
Journal:  Nature       Date:  1993-05-13       Impact factor: 49.962

7.  An experimentally validated panel of subfamily-specific oligonucleotide primers (V alpha 1-w29/V beta 1-w24) for the study of human T cell receptor variable V gene segment usage by polymerase chain reaction.

Authors:  C Genevée; A Diu; J Nierat; A Caignard; P Y Dietrich; L Ferradini; S Roman-Roman; F Triebel; T Hercend
Journal:  Eur J Immunol       Date:  1992-05       Impact factor: 5.532

Review 8.  Dengue and dengue hemorrhagic fever.

Authors:  D J Gubler
Journal:  Clin Microbiol Rev       Date:  1998-07       Impact factor: 26.132

9.  Separation of IL-4 production from Th cell proliferation by an altered T cell receptor ligand.

Authors:  B D Evavold; P M Allen
Journal:  Science       Date:  1991-05-31       Impact factor: 47.728

10.  Altered peptide ligands can control CD4 T lymphocyte differentiation in vivo.

Authors:  C Pfeiffer; J Stein; S Southwood; H Ketelaar; A Sette; K Bottomly
Journal:  J Exp Med       Date:  1995-04-01       Impact factor: 14.307

View more
  35 in total

1.  Protection from secondary dengue virus infection in a mouse model reveals the role of serotype cross-reactive B and T cells.

Authors:  Simona Zompi; Brian H Santich; P Robert Beatty; Eva Harris
Journal:  J Immunol       Date:  2011-11-30       Impact factor: 5.422

2.  Homology of complete genome sequences for dengue virus type-1, from dengue-fever- and dengue-haemorrhagic-fever-associated epidemics in Hawaii and French Polynesia.

Authors:  A Imrie; C Roche; Z Zhao; S Bennett; M Laille; P Effler; V-M Cao-Lormeau
Journal:  Ann Trop Med Parasitol       Date:  2010-04

3.  Mapping and Role of the CD8+ T Cell Response During Primary Zika Virus Infection in Mice.

Authors:  Annie Elong Ngono; Edward A Vizcarra; William W Tang; Nicholas Sheets; Yunichel Joo; Kenneth Kim; Matthew J Gorman; Michael S Diamond; Sujan Shresta
Journal:  Cell Host Microbe       Date:  2017-01-11       Impact factor: 21.023

Review 4.  Elucidating the role of T cells in protection against and pathogenesis of dengue virus infections.

Authors:  Anuja Mathew; Elizabeth Townsley; Francis A Ennis
Journal:  Future Microbiol       Date:  2014       Impact factor: 3.165

5.  Intracellular cytokine production by dengue virus-specific T cells correlates with subclinical secondary infection.

Authors:  Steven Hatch; Tim P Endy; Stephen Thomas; Anuja Mathew; James Potts; Pamela Pazoles; Daniel H Libraty; Robert Gibbons; Alan L Rothman
Journal:  J Infect Dis       Date:  2011-02-18       Impact factor: 5.226

Review 6.  Immunity to dengue virus: a tale of original antigenic sin and tropical cytokine storms.

Authors:  Alan L Rothman
Journal:  Nat Rev Immunol       Date:  2011-07-15       Impact factor: 53.106

7.  Identification of serotype-specific T cell responses to highly conserved regions of the dengue viruses.

Authors:  G N Malavige; S McGowan; V Atukorale; M Salimi; M Peelawatta; N Fernando; S D Jayaratne; G Ogg
Journal:  Clin Exp Immunol       Date:  2012-05       Impact factor: 4.330

8.  HLA Class I Supertype Associations With Clinical Outcome of Secondary Dengue Virus Infections in Ethnic Thais.

Authors:  Sasijit Vejbaesya; Rungrot Thongpradit; Siripen Kalayanarooj; Komon Luangtrakool; Panpimon Luangtrakool; Robert V Gibbons; Duangporn Srinak; Somporn Ngammthaworn; Kusuma Apisawes; In-Kyu Yoon; Stephen J Thomas; Richard G Jarman; Anon Srikiakthachorn; Sharone Green; Dasnayanee Chandanayingyong; Sangshin Park; Jennifer Friedman; Alan L Rothman; Henry A F Stephens
Journal:  J Infect Dis       Date:  2015-03-04       Impact factor: 5.226

9.  Memory CD8+ T cells from naturally acquired primary dengue virus infection are highly cross-reactive.

Authors:  Heather Friberg; Lynne Burns; Marcia Woda; Siripen Kalayanarooj; Timothy P Endy; Henry A F Stephens; Sharone Green; Alan L Rothman; Anuja Mathew
Journal:  Immunol Cell Biol       Date:  2010-04-27       Impact factor: 5.126

10.  Differential targeting of viral components by CD4+ versus CD8+ T lymphocytes in dengue virus infection.

Authors:  Laura Rivino; Emmanuelle A P Kumaran; Vojislav Jovanovic; Karen Nadua; En Wei Teo; Shyue Wei Pang; Guo Hui Teo; Victor Chih Hao Gan; David C Lye; Yee Sin Leo; Brendon J Hanson; Kenneth G C Smith; Antonio Bertoletti; David M Kemeny; Paul A MacAry
Journal:  J Virol       Date:  2012-12-19       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.